FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993524800> ?p ?o ?g. }

• W1993524800 endingPage "1229" @default.
• W1993524800 startingPage "1219" @default.
• W1993524800 abstract "In vivo production of recombinant antibodies by engineered cells may have applications for gene therapy of certain cancers and of certain severe viral diseases. It would also permit the development of new animal models of autoimmune diseases and new approaches for in vivo ablation of specific cell types for fundamental purposes. Using gene transfer of an anti-human thyroglobulin monoclonal antibody, we show here that several cell types permitting autologous grafting of genetically engineered cells are efficiently able to secrete antibodies in vitro. Those cells include skin fibroblasts, hepatocytes, and myogenic cells. We also show that the secreted antibodies display an affinity for the antigen close to that of the parental antibody, with, however, slight differences varying according to the cell type. This indicates that the foldings of antigen combining sites of antibodies produced in B cell- and non-B cell contexts are very similar. Finally, we report that, when implanted in the forelimb of a mouse, genetically modified myogenic cells are able to secrete antibodies for at least 4 months. Taken together, our observations point to the notion that genetic modification of patient cells may be used for long-term antibody-based gene therapies. Expression of cloned antibodies by genetically modified cells of patients may be used for developing surveillance treatments after primary anticancer therapies such as surgery, chemotherapies, or radiotherapies to avoid relapse or for inhibiting virus proliferation in the case of severe viral diseases. Because of their short life span and because of the fact that they already produce an antibody, plasmocytes from patients cannot be used for such a purpose. It is shown here that several cell types amenable to genetic modification and grafting to patients and which include skin fibroblasts, myogenic cells, and hepatocytes can produce cloned antibodies retaining the specificity and the affinity of the parental antibody. Grafting of engineered myogenic cells to mice also showed that delivery of recombinant antibodies in the blood stream was possible in vivo. This work casts the cellular basis for new antibody-based gene therapies and also more fundamental applications such as specific cell ablation and the study of certain aspects of autoimmunity." @default.
• W1993524800 created "2016-06-24" @default.
• W1993524800 creator A5014980356 @default.
• W1993524800 creator A5024605869 @default.
• W1993524800 creator A5027906050 @default.
• W1993524800 creator A5057509693 @default.
• W1993524800 creator A5058659512 @default.
• W1993524800 creator A5081250910 @default.
• W1993524800 creator A5083121277 @default.
• W1993524800 date "1997-07-01" @default.
• W1993524800 modified "2023-10-15" @default.
• W1993524800 title "In VitroandIn VivoSecretion of Cloned Antibodies by Genetically Modified Myogenic Cells" @default.
• W1993524800 cites W1851078730 @default.
• W1993524800 cites W1967768492 @default.
• W1993524800 cites W1971680829 @default.
• W1993524800 cites W1972201132 @default.
• W1993524800 cites W1979041350 @default.
• W1993524800 cites W2005275397 @default.
• W1993524800 cites W2009443641 @default.
• W1993524800 cites W2010413800 @default.
• W1993524800 cites W2023814923 @default.
• W1993524800 cites W2025339753 @default.
• W1993524800 cites W2029625075 @default.
• W1993524800 cites W2034511195 @default.
• W1993524800 cites W2054948523 @default.
• W1993524800 cites W2056811231 @default.
• W1993524800 cites W2079723355 @default.
• W1993524800 cites W2089652099 @default.
• W1993524800 cites W2090781939 @default.
• W1993524800 cites W2100340467 @default.
• W1993524800 cites W2110393059 @default.
• W1993524800 cites W2159665192 @default.
• W1993524800 cites W2162087337 @default.
• W1993524800 cites W4229992754 @default.
• W1993524800 cites W4230527064 @default.
• W1993524800 cites W4256704256 @default.
• W1993524800 doi "https://doi.org/10.1089/hum.1997.8.10-1219" @default.
• W1993524800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9215739" @default.
• W1993524800 hasPublicationYear "1997" @default.
• W1993524800 type Work @default.
• W1993524800 sameAs 1993524800 @default.
• W1993524800 citedByCount "35" @default.
• W1993524800 countsByYear W19935248002013 @default.
• W1993524800 countsByYear W19935248002015 @default.
• W1993524800 countsByYear W19935248002016 @default.
• W1993524800 countsByYear W19935248002020 @default.
• W1993524800 countsByYear W19935248002021 @default.
• W1993524800 crossrefType "journal-article" @default.
• W1993524800 hasAuthorship W1993524800A5014980356 @default.
• W1993524800 hasAuthorship W1993524800A5024605869 @default.
• W1993524800 hasAuthorship W1993524800A5027906050 @default.
• W1993524800 hasAuthorship W1993524800A5057509693 @default.
• W1993524800 hasAuthorship W1993524800A5058659512 @default.
• W1993524800 hasAuthorship W1993524800A5081250910 @default.
• W1993524800 hasAuthorship W1993524800A5083121277 @default.
• W1993524800 hasConcept C104317684 @default.
• W1993524800 hasConcept C111599444 @default.
• W1993524800 hasConcept C147483822 @default.
• W1993524800 hasConcept C153911025 @default.
• W1993524800 hasConcept C159047783 @default.
• W1993524800 hasConcept C159654299 @default.
• W1993524800 hasConcept C203014093 @default.
• W1993524800 hasConcept C207001950 @default.
• W1993524800 hasConcept C51456166 @default.
• W1993524800 hasConcept C542903549 @default.
• W1993524800 hasConcept C54355233 @default.
• W1993524800 hasConcept C86803240 @default.
• W1993524800 hasConceptScore W1993524800C104317684 @default.
• W1993524800 hasConceptScore W1993524800C111599444 @default.
• W1993524800 hasConceptScore W1993524800C147483822 @default.
• W1993524800 hasConceptScore W1993524800C153911025 @default.
• W1993524800 hasConceptScore W1993524800C159047783 @default.
• W1993524800 hasConceptScore W1993524800C159654299 @default.
• W1993524800 hasConceptScore W1993524800C203014093 @default.
• W1993524800 hasConceptScore W1993524800C207001950 @default.
• W1993524800 hasConceptScore W1993524800C51456166 @default.
• W1993524800 hasConceptScore W1993524800C542903549 @default.
• W1993524800 hasConceptScore W1993524800C54355233 @default.
• W1993524800 hasConceptScore W1993524800C86803240 @default.
• W1993524800 hasIssue "10" @default.
• W1993524800 hasLocation W19935248001 @default.
• W1993524800 hasLocation W19935248002 @default.
• W1993524800 hasLocation W19935248003 @default.
• W1993524800 hasOpenAccess W1993524800 @default.
• W1993524800 hasPrimaryLocation W19935248001 @default.
• W1993524800 hasRelatedWork W1602847563 @default.
• W1993524800 hasRelatedWork W1973692620 @default.
• W1993524800 hasRelatedWork W1997716688 @default.
• W1993524800 hasRelatedWork W2038126255 @default.
• W1993524800 hasRelatedWork W2063428357 @default.
• W1993524800 hasRelatedWork W2064089409 @default.
• W1993524800 hasRelatedWork W2073262237 @default.
• W1993524800 hasRelatedWork W2076922394 @default.
• W1993524800 hasRelatedWork W2368460920 @default.
• W1993524800 hasRelatedWork W2380360044 @default.
• W1993524800 hasVolume "8" @default.
• W1993524800 isParatext "false" @default.
• W1993524800 isRetracted "false" @default.

• next